Zobrazeno 1 - 10
of 49
pro vyhledávání: '"G, Houvenaeghel"'
Autor:
Yves Fouche, Marc Baron, Florent Boutitie, G. Houvenaeghel, Daniel Raudrant, Eric Leblanc, Catherine Uzan, V. Fourchotte, J-M Classe, P. Morice, Anne-Sophie Bats, Fabrice Lecuru, C. Pomel, L. Boulanger, Jean Levêque, G. Mage, Olivier Graesslin, Patrice Mathevet, Frederic Guyon, Emile Daraï, Vanessa Conri, Philippe Descamps, Jean-Jacques Baldauf, Henri Marret, A S Bats, Denis Querleu, Virginie Fourchotte, Laurent Magaud, B. Ott, Serge Douvier, E. Stoeckle, P. Rouanet, P. Mathevet, Manuel González Barón, D. Lanvin, Y. Delpech
Publikováno v:
European Journal of Cancer. 148:307-315
Introduction Pelvic lymph node dissection has been the standard of care for patients with early cervical cancer. Sentinel node (SN) mapping is safe and feasible and may increase the detection of metastatic disease, but benefits of omitting pelvic lym
Autor:
J.M. Extra, Patrick Sfumato, Christophe Ginestier, J-Y Pierga, G. Houvenaeghel, A. Gonçalves, Hervé Curé, E Charafe-Jauffret, Eric Lambaudie, Renaud Sabatier
Publikováno v:
Cancer Research. 79:P2-10
Background. Preclinical works have suggested that conventional cytotoxic chemotherapies may increase the number of cancer stem cells. Angiogenesis inhibition has been described in vitro to have an impact on stem cells proliferation. We developed a pr
Autor:
P. Gimbergues, Roman Rouzier, X Murraciole, Nicolas Chopin, Monique Cohen, Eric Lambaudie, M.-P. Chauvet, G. Houvenaeghel, P-E. Colombo, Chafika Mazouni, Aubert Agostini, A. Gonçalves, J-M Classe, A.-S. Azuar, Armando J. Martínez, Emile Daraï, A. De Nonneville, C. Tunon de Lara, Fabien Reyal, Charles Coutant
Publikováno v:
Cancer Research. 79:P2-08
Background Tumour features associated with isolated invasive breast cancer ipsilateral local recurrence (ILR) after breast conservative treatment (BCT) and consequences on overall survival (OS) are still debated. The aim of our study was to examine p
Autor:
A Boucraut, Raphaëlle Duprez-Paumier, Frédérique Penault-Llorca, Monique Cohen, G. Houvenaeghel, Emmanuelle Charafe-Jauffret, Anne Pradines, Magali Lacroix-Triki, C Maroc, A Berghian, Anne Cayre, M.M. Dauplat, P Etancelin
Publikováno v:
Cancer Research. 79:P3-11
Background Several validated molecular subtyping tests for breast cancer based on gene expression profiling are now routinely used in clinical practice.The Prosigna® breast cancer (BC) prognostic gene signature assay identifies a gene-expression pro
Publikováno v:
European Journal of Surgical Oncology. 44:1929-1934
INTRODUCTION The objective of this study was to report a 30-year experience of PE for gynecologic malignancies in a cancer center. MATERIALS AND METHODS A retrospective study was conducted at Institut Paoli-Calmette including patients who underwent P
Autor:
C. Ngo, E. Barranger, C. Tunon de Lara, C. Palpacuer, G. Ferron, Séverine Alran, Cécile Loaec, Pierre Gimbergues, M.-P. Chauvet, Pierre-François Dupré, G. Houvenaeghel, C. Faure, Marian Gutowski, Jean-Luc Verhaeghe, P De Blay, Roman Rouzier, Loïc Campion, Celine Lefebvre, Jean-Marc Classe, Nicolas Paillocher
Publikováno v:
Breast Cancer Research and Treatment. 173:343-352
GANEA2 study was designed to assess accuracy and safety of sentinel lymph node (SLN) after neo-adjuvant chemotherapy (NAC) in breast cancer patients. Early breast cancer patients treated with NAC were included. Before NAC, patients with cytologically
Autor:
Monique Cohen, Nicolas Chopin, G. Houvenaeghel, Eric Lambaudie, Fabien Reyal, Pierre-Emmanuel Colombo, J-M Classe, S. Giard, Xavier Muracciole, A. Gonçalves, A. De Nonneville
Publikováno v:
Cancer Research. 78:P1-13
Background: Recent updated analysis of the HERA (HERceptin Adjuvant) trial indicate that tumor hormone receptor status (HR)remains a major determinant of outcome in HER2-positive (HER2+) early breast cancer (BC) patients, with higher rates of recurre
Autor:
J, Dauplat, F, Kwiatkowski, P, Rouanet, E, Delay, K, Clough, J L, Verhaeghe, I, Raoust, G, Houvenaeghel, P, Lemasurier, E, Thivat, C, Pomel, D, Weitbruch
Publikováno v:
British Journal of Surgery
British Journal of Surgery, Wiley, 2017, 104 (9), pp.1197-1206. ⟨10.1002/bjs.10537⟩
British Journal of Surgery, Wiley, 2017, 104 (9), pp.1197-1206. ⟨10.1002/bjs.10537⟩
Background Mastectomy with immediate breast reconstruction (IBR) is a surgical strategy in breast cancer when breast-conserving surgery is not an option. There is a lack of evidence showing an advantage of mastectomy plus IBR over mastectomy alone on
Autor:
J.-R. Garbay, Emile Daraï, Eric Lambaudie, G Houvenaeghel, Fabien Reyal, J-M Classe, Richard Villet, Renaud Sabatier, C. Faure, Roman Rouzier, S. Giard, H. Charitansky, Delphine Hudry, Pierre Gimbergues
Publikováno v:
British Journal of Cancer
Background: Triple-negative breast cancers (TNBCs) are the most deadly form of breast cancer (BC) subtypes. Axillary lymph node involvement (ALNI) has been described to be prognostic in BC taken as a whole, but its prognostic value in each subtype is
Autor:
Marie Bannier, Fabien Reyal, Charles Coutant, J-M Classe, Armando J. Martínez, A. Berthelot, Emile Daraï, A. De Nonneville, Monique Cohen, M.-P. Chauvet, P. Guimbergues, R. Villet, G. Houvenaeghel, A. Gonçalves, Chafika Mazouni, C. Tunon de Lara, Nicolas Chopin, Roman Rouzier, A.-S. Azuar
Publikováno v:
Annals of Oncology. 30:v64
Background Elderly breast cancer (BC) patients have been underrepresented in clinical trials whereas ∼60% of deaths from BC occur in women aged 65 years and older. The management of elderly women with early BC requires careful evaluation of risks a